🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Stephen Eng

Memorial Sloan Kettering Cancer Center

ORCID: 0000-0002-1929-5705

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Phase 2 trial of cyclosporine-A, mycophenolate mofetil, and tocilizumab GVHD prophylaxis in cord blood transplantation”.

Phase 2 trial of cyclosporine-A, mycophenolate mofetil, and tocilizumab GVHD prophylaxis in cord blood transplantation

Blood Advances(2025)10.1182/bloodadvances.2024014177

N/A

0.208DataRank · unranked

3 citations

Samantha Brown, Joshua Fein, Stephen Eng, Kristian Casem, Stephanie Chinapen +18 more

Updates in chronic graft-versus-host disease: novel treatments and best practices in the current era

Bone Marrow Transplantation(2024)10.1038/s41409-024-02370-8

N/A

0DataRank · unranked

26 citations

Stephen Eng, Anthony Proli, Doris M. Ponce, Grashma Vadakkel

Insurance Barriers to High-Cost Anti-Infective Medications Post Allogeneic Hematopoietic Cell Transplant

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.07.006

N/A

0DataRank · unranked

0 citations

Grashma Vadakkel, Samantha Brown, Susan Murillo, Warren Fingrut, Sean Devlin +12 more